128 related articles for article (PubMed ID: 23155441)
21. Medication effectiveness with the use of tumor necrosis factor inhibitors among Texas Medicaid patients diagnosed with rheumatoid arthritis.
Oladapo A; Barner JC; Lawson KA; Novak S; Rascati KL; Richards KM; Harrison DJ
J Manag Care Spec Pharm; 2014 Jul; 20(7):657-67. PubMed ID: 24967519
[TBL] [Abstract][Full Text] [Related]
22. Therapies for active rheumatoid arthritis after methotrexate failure.
O'Dell JR; Mikuls TR; Taylor TH; Ahluwalia V; Brophy M; Warren SR; Lew RA; Cannella AC; Kunkel G; Phibbs CS; Anis AH; Leatherman S; Keystone E;
N Engl J Med; 2013 Jul; 369(4):307-18. PubMed ID: 23755969
[TBL] [Abstract][Full Text] [Related]
23. Malignancy risk of anti-tumor necrosis factor alpha blockers: an overview of systematic reviews and meta-analyses.
Chen Y; Sun J; Yang Y; Huang Y; Liu G
Clin Rheumatol; 2016 Jan; 35(1):1-18. PubMed ID: 26573205
[TBL] [Abstract][Full Text] [Related]
24. Randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of etanercept in patients with moderately active rheumatoid arthritis despite DMARD therapy.
Hobbs K; Deodhar A; Wang B; Bitman B; Nussbaum J; Chung J; Collier DH
Springerplus; 2015; 4():113. PubMed ID: 25793152
[TBL] [Abstract][Full Text] [Related]
25. Comparative effectiveness of less commonly used systemic monotherapies and common combination therapies for moderate to severe psoriasis in the clinical setting.
Takeshita J; Wang S; Shin DB; Callis Duffin K; Krueger GG; Kalb RE; Weisman JD; Sperber BR; Stierstorfer MB; Brod BA; Schleicher SM; Robertson AD; Linn KA; Shinohara RT; Troxel AB; Van Voorhees AS; Gelfand JM
J Am Acad Dermatol; 2014 Dec; 71(6):1167-75. PubMed ID: 25260564
[TBL] [Abstract][Full Text] [Related]
26. Comparative efficacy of biologics as monotherapy and in combination with methotrexate on patient reported outcomes (PROs) in rheumatoid arthritis patients with an inadequate response to conventional DMARDs--a systematic review and network meta-analysis.
Jansen JP; Buckley F; Dejonckheere F; Ogale S
Health Qual Life Outcomes; 2014 Jul; 12():102. PubMed ID: 24988902
[TBL] [Abstract][Full Text] [Related]
27. The risk of serious infection in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors decreased over time: a report from the registry of Japanese rheumatoid arthritis patients on biologics for long-term safety (REAL) database.
Sakai R; Cho SK; Nanki T; Koike R; Watanabe K; Yamazaki H; Nagasawa H; Amano K; Tanaka Y; Sumida T; Ihata A; Yasuda S; Nakajima A; Sugihara T; Tamura N; Fujii T; Dobashi H; Miura Y; Miyasaka N; Harigai M;
Rheumatol Int; 2014 Dec; 34(12):1729-36. PubMed ID: 24852650
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety of infliximab-biosimilar compared to other biological drugs in rheumatoid arthritis: a mixed treatment comparison.
Baji P; Péntek M; Czirják L; Szekanecz Z; Nagy G; Gulácsi L; Brodszky V
Eur J Health Econ; 2014 May; 15 Suppl 1(Suppl 1):S53-64. PubMed ID: 24832836
[TBL] [Abstract][Full Text] [Related]
29. Cost effectiveness of biologic therapies for plaque psoriasis.
Ahn CS; Gustafson CJ; Sandoval LF; Davis SA; Feldman SR
Am J Clin Dermatol; 2013 Aug; 14(4):315-26. PubMed ID: 23696234
[TBL] [Abstract][Full Text] [Related]
30. OBSERVE-5 interim analysis: an observational postmarketing safety registry of etanercept for the treatment of psoriasis.
Kimball AB; Pariser D; Yamauchi PS; Menter A; Teller CF; Shi Y; Yong M; Creamer K; Hooper M; Aras G; Kricorian G; Gelfand JM
J Am Acad Dermatol; 2013 May; 68(5):756-64. PubMed ID: 23357569
[TBL] [Abstract][Full Text] [Related]
31. The immunogenicity of anti-TNF therapy in immune-mediated inflammatory diseases: a systematic review of the literature with a meta-analysis.
Garcês S; Demengeot J; Benito-Garcia E
Ann Rheum Dis; 2013 Dec; 72(12):1947-55. PubMed ID: 23223420
[TBL] [Abstract][Full Text] [Related]
32. Melanoma associated with tumour necrosis factor-α inhibitors: a Research on Adverse Drug events And Reports (RADAR) project.
Nardone B; Hammel JA; Raisch DW; Weaver LL; Schneider D; West DP
Br J Dermatol; 2014 May; 170(5):1170-2. PubMed ID: 24328939
[TBL] [Abstract][Full Text] [Related]
33. Malignancies in children and young adults on etanercept: summary of cases from clinical trials and post marketing reports.
Hooper M; Wenkert D; Bitman B; Dias VC; Bartley Y
Pediatr Rheumatol Online J; 2013 Oct; 11(1):35. PubMed ID: 24225257
[TBL] [Abstract][Full Text] [Related]
34. Risk of extraintestinal solid cancer with anti-TNF therapy in adults with inflammatory bowel disease: review of the literature.
Hudesman D; Lichtiger S; Sands B
Inflamm Bowel Dis; 2013 Mar; 19(3):644-9. PubMed ID: 23314243
[TBL] [Abstract][Full Text] [Related]
35. Golimumab (anti-TNF monoclonal antibody): where we stand today.
Melo AT; Campanilho-Marques R; Fonseca JE
Hum Vaccin Immunother; 2021 Jun; 17(6):1586-1598. PubMed ID: 33369527
[TBL] [Abstract][Full Text] [Related]
36. ATYPICAL RECURRENCE OF PARATHYROID CARCINOMA FOLLOWING INFLIXIMAB THERAPY IN A PATIENT WITH ULCERATIVE COLITIS.
Gunawan F; Holt E
AACE Clin Case Rep; 2020; 6(3):e113-e116. PubMed ID: 32524023
[TBL] [Abstract][Full Text] [Related]
37. Risk of non-melanoma skin cancer for rheumatoid arthritis patients receiving TNF antagonist: a systematic review and meta-analysis.
Wang JL; Yin WJ; Zhou LY; Zhou G; Liu K; Hu C; Zuo XC; Wang YF
Clin Rheumatol; 2020 Mar; 39(3):769-778. PubMed ID: 31823140
[TBL] [Abstract][Full Text] [Related]
38. Down-regulation of microRNA-142-3p inhibits the aggressive phenotypes of rheumatoid arthritis fibroblast-like synoviocytes through inhibiting nuclear factor-κB signaling.
Qiang J; Lv T; Wu Z; Yang X
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31239367
[TBL] [Abstract][Full Text] [Related]
39. TNF-α inhibitors in the treatment of hidradenitis suppurativa.
Savage KT; Flood KS; Porter ML; Kimball AB
Ther Adv Chronic Dis; 2019; 10():2040622319851640. PubMed ID: 31191873
[TBL] [Abstract][Full Text] [Related]
40. Malignancy Risk and Recurrence with Psoriasis and its Treatments: A Concise Update.
Geller S; Xu H; Lebwohl M; Nardone B; Lacouture ME; Kheterpal M
Am J Clin Dermatol; 2018 Jun; 19(3):363-375. PubMed ID: 29260411
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
